@prof-ali-g
Professor of Precision Oncology at Newcastle and Clinical Director NE England Genomic Medicine Service. Interests include drug development especially in thoracic malignancy; biomarkers including cfDNA and treatment of older patients with cancer
With apologies to Scotland ๐ด๓ ง๓ ข๓ ณ๓ ฃ๓ ด๓ ฟ for ignorance looks like similarly to England ๐ด๓ ง๓ ข๓ ฅ๓ ฎ๓ ง๓ ฟ tepotinib available independent of line; although I would recommend as 1st line treatment as discussed
BTOG does โฆ MET podcast is now released โ this is part fiveย of a series looking at mutations in lung cancerโจย โจRecorded recently, I discussed MET and treatment with @tnewsomdavis.bsky.social
You can subscribe to BTOG podcasts through usual channels โ just search BTOG, or listen via BTOG website.
How to get to emergency presentation patients?
Modelling of ability to โturn offโ tumour analysis for some patients
Guidelines on above for Genomic labs /Pathology/Oncology
We delivered a cost-effective national service with improvements in TAT and patient care. Questions still to be answered include
Impact on treatment and outcomes
How to move to business as usual?
How to integrate results with pathology and clinical notes?
Presented today at #RCPathGenomics about NHSE cfDNA pilot. Token oncologist in the room. Not sure what @bsky.app version of a tweetorial is. Issues addressed within the pilot can be found at www.roche-images.co.uk/Genomics_Lun...
Me please ๐ซก
Essays funded by @astrazeneca.bsky.social
Donโt think any of others here yet
@newcastleuni.bsky.social
Quoting from Prof Simcock of MacMilllan on X in hope will be of interest to friends and colleagues on the new and better platform.
Thoughts from him, me et al.
โCan you imagine a world with zero cancer deaths? And what would it take to get there?
learn.az/6042srIWu
โ
@gerryhanna.bsky.social @jia-b.bsky.social @drpeedell.bsky.social
Need somebody to set-up one of those useful starter packs to find us all and start the conversation @bsky.app . Need to get BTOG and Professor P over here too ๐